In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

Sunesis completes $39.06mm IPO

Executive Summary

Sunesis Pharmaceuticals (therapeutics for cancer and inflammatory diseases) has netted $39.06mm with the initial public offering of 6mm common shares priced at $7 each. The company had originally hoped to bring in up to $86.25mm when it first filed in December 2004.

Deal Industry
  • Biotechnology
  • Pharmaceuticals
Deal Status
  • Final
Deal Type
  • Financing
    • IPO

Related Companies